For the biomedical community, the panel’s creation carries particular importance. AI innovation is advancing faster than regulators, clinicians and patients can evaluate it, and a growing chorus argues that yesterday’s guardrails are today’s constraints. The panel’s appointment signals that countries still view independent scientific assessment as being essential to realizing AI’s promise in health (and other domains).
The panel’s origins lie in the Global Digital Compact, adopted at the UN’s 2024 Summit of the Future as part of the Pact for the Future. That agreement committed member states to establishing both an independent scientific body and a Global Dialogue on AI Governance — two complementary mechanisms to ground international deliberations in evidence rather than assumption. In August 2025, the UN General Assembly formalized the arrangement through resolution A/RES/79/325, defining the panel’s mandate, its relationship to the global dialogue, and the requirement that members serve in their personal capacities, independently of any government, company or institution. The panel is supported by a secretariat housed in the UN Office for Digital and Emerging Technologies.
— Source: Nature Medicine (https://www.nature.com/articles/s41591-026-04375-w)
